Health care investors are entering both the final stretch of 2018 and the final weeks of a GOP-controlled House of Representatives. Height Capital Markets analyst Andrea Harris surveyed nine potential health care catalysts that investors should be watching between now and the end of December in a recent note.
Of the nine potential legislative catalysts ahead in the next month, Harris said she expects two of them to pass: measures that would financially impact Roche Holdings AG Basel ADR Common Stock RHHBY, Sanofi SA SNY, Takeda Pharmaceutical Co Ltd TKPYY, Merck & Co., Inc. MRK, Cardinal Health Inc CAH, GlaxoSmithKline plc GSK, Johnson & Johnson JNJ, and Procter & Gamble Co PG.
Two Imminent Measures
“We believe that a reauthorization of the Pandemic and All-Hazards Preparedness Act (S. 2852) and the Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 (H.R. 5333) stand the best chance of passage this year,” Harris said.
Other key pieces of health care legislation might still make it through in 2019 as well, the analyst said.
“We further believe that legislation to address health care taxes (device tax, Cadillac tax and the health insurer fee) and drug pricing legislation (BBA fix, TrOOP cliff fix, and CREATES Act) are possible to enact in 2018, but Congress will more likely address these issues in 2019."
Other Impacted Stocks
Other pieces of legislation could impact additional companies, Harris said:
- Anthem Inc ANTM
- Aetna Inc AET
- CIGNA Corporation CI
- Humana Inc HUM
- Centene Corp CNC
- Molina Healthcare, Inc. MOH
- UnitedHealth Group Inc UNH
- WellCare Health Plans, Inc. WCG
- Becton Dickinson and Co BDX
- Boston Scientific Corporation BSX
- Edwards Lifesciences Corp EW
- Medtronic PLC MDT
- Stryker Corporation SYK
- Mylan NV MYL
- Teva Pharmaceutical Industries Ltd ADR TEVA
- Celgene Corporation CELG
- Gilead Sciences, Inc. GILD
- Amgen, Inc. AMGN
- AbbVie Inc ABBV
- Pfizer Inc. PFE
- Healthequity Inc HQY
- UnitedHealth Group Inc UNH
- Webster Financial Corporation WBS
The Height Capital chart below indicates which legislative measures the firm believes are likely to pass and which specific stocks could be impacted:
Related Links:
The Health Care Stocks With A Lot Riding On The Midterm Elections
With Tether In Focus, The DoJ Is Investigating Last Year's Cryptomania
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.